Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercializing branded and generic pharmaceuticals with operations in the USA and Australia. The Australian division is focused on developing and manufacturing oral solids for its own IP and contract customers as a true CDMO exporting to Asia, Europe, North America, and South America. The commercial division sells and markets a range of in-licensed and owned IP products in the ANZ region. These are primarily in the women"s health and dermatology sectors and various consumer and over-the-counter products.
Visit Company Website
